UPDATED May 20, 2024
Discover large cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
LLY | US$783.18 | 3.4% | 80.5% | US$693.3b | US$850.41 | PE114.9x | E27.3% | 0.7% | ||
NOVO B | kr.903.30 | -0.7% | 53.1% | kr.4.0t | kr.909.23 | PE44.9x | E13.3% | 1.0% | ||
JNJ | US$151.27 | 0.03% | -3.6% | US$372.2b | US$173.26 | PE21.3x | E6.9% | 3.3% | ||
MRK | US$130.99 | 1.3% | 14.4% | US$332.3b | US$141.64 | PE143.9x | E24.1% | 2.4% | ||
ABBV | US$164.56 | 2.0% | 13.6% | US$293.9b | US$182.26 | PE48.8x | E23.3% | 3.8% | ||
AZN | UK£120.96 | -1.8% | 0.5% | UK£187.5b | UK£132.11 | PE37.6x | E15.0% | 2.0% | ||
TMO | US$594.01 | 0.6% | 12.3% | US$227.2b | US$627.27 | PE37.6x | E10.6% | 0.3% | ||
ROG | CHF237.10 | 4.1% | -17.2% | CHF191.3b | CHF279.39 | PE16.4x | E8.7% | 4.0% | ||
NOVN | CHF93.37 | 0.3% | 2.3% | CHF190.5b | CHF98.13 | PE23x | E10.2% | 3.5% | ||
DHR | US$267.11 | 6.2% | 15.5% | US$196.9b | US$272.68 | PE48.6x | E13.5% | 0.4% | ||
AMGN | US$314.54 | 2.0% | 40.4% | US$167.6b | US$316.06 | PE44.8x | E17.9% | 2.9% | ||
PFE | US$28.53 | 0.3% | -26.4% | US$162.3b | US$31.94 | PS2.9x | E28.9% | 5.9% | ||
SAN | €89.16 | -3.8% | -11.1% | €111.5b | €108.34 | PE24.6x | E16.9% | 4.2% | ||
VRTX | US$445.87 | 3.7% | 31.1% | US$114.9b | US$462.55 | PE28.6x | E10.1% | n/a | ||
REGN | US$987.27 | 1.1% | 31.4% | US$106.0b | US$1,041.93 | PE27.6x | E12.5% | n/a | ||
GSK | UK£17.75 | -1.9% | 24.5% | UK£72.4b | UK£20.32 | PE16.1x | E12.2% | 3.3% | ||
CSL | AU$277.63 | -0.7% | -10.2% | AU$134.3b | AU$302.62 | PE36.1x | E14.7% | 1.3% | ||
BMY | US$43.36 | -3.8% | -34.1% | US$89.3b | US$53.19 | PS1.9x | E44.7% | 5.5% | ||
GILD | US$67.90 | 0.5% | -13.6% | US$84.4b | US$82.93 | PE174.4x | E36.5% | 4.5% | ||
ZTS | US$174.39 | 3.9% | -2.9% | US$79.4b | US$211.20 | PE33.3x | E8.6% | 1.0% | ||
MRK | €166.55 | 7.8% | 0.3% | €72.4b | €182.31 | PE26.6x | E11.6% | 1.3% | ||
4568 | JP¥5,496.00 | 1.5% | 12.8% | JP¥10.6t | JP¥5,853.33 | PE52.5x | E18.6% | 1.1% | ||
4519 | JP¥5,036.00 | 5.0% | 34.6% | JP¥8.3t | JP¥6,021.43 | PE25.4x | E5.8% | 1.6% | ||
MRNA | US$141.01 | 12.2% | 11.3% | US$50.9b | US$138.51 | PS10.5x | E68.8% | n/a |